Doxepin Hydrochloride
Product Images NDC 21695-441
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 21695-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Doxepin HCl 10mg (F6ffd0d8 3451 425e 921e Faae1c1b8ad3 02)
This is a description of a medication called Doxepin HCI, which comes in a capsule form with a buff opaque cap and body that is axially printed with "MYLAN" over "*1049" in black ink on both the cap and body. Each capsule contains 10mg of Doxepin HCI, with a total of 30 capsules per bottle. The medication is manufactured by Mylan Pharmaceuticals Inc. and packaged by Physician Partner, and it should be stored at a controlled room temperature of 15°-30°C (59>86°F). It is advised to keep the medication out of reach of children.*
Doxepin HCl 50mg (F6ffd0d8 3451 425e 921e Faae1c1b8ad3 03)
This is a medication called "Doxepin HCI 50mg". Each package contains 30 capsules. It is distributed by Mylan Pharmaceuticals Inc. and packaged by Physician Partner. The capsules are hard-shell, gelatin capsules with an ivory opaque cap and a wory opaque body printed with "MYLAN" over "4250" on both the cap and the body. The medication should be stored at controlled room temperature 15°-30°C (59°-86°F) and kept out of the reach of children. The product identifier is PD094330.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.